APP
CDMO

Alpha Paradigm Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Alpha Paradigm Partners’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-35,671
Closed -$544K – 662
2022
Q2 		$544K Buy
+35,671
New +$528K 0.22% 159

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alpha Paradigm Partners's CDMO Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 35,671 shares — an estimated $544K sold.

Alpha Paradigm Partners first reported a position in CDMO in Q2 2022 and held it in 1 quarter. The position peaked at $544K in Q2 2022. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

  • Alpha Paradigm Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 35,671 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $544K.
  • Alpha Paradigm Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Alpha Paradigm Partners's Avid Bioservices, Inc. Common Stock position peaked at $544K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.